Table 1.
Virus | Cancers with sufficient evidence | Cancers with limited evidence |
---|---|---|
EBV | Nasopharyngeal carcinoma Burkitt’s Lymphoma Immunesuppression-related non- Hodgkin lymphoma, Extranodal NK/T cell lymphoma (nasal type), Hodgkin’s lymphoma |
Gastric carcinoma Lympho-epithelioma-like carcinoma Plasmablastic lymphoma Diffuse large B-cell/immunoblastic lymphoma (DLBCL) |
HHV-8 | Kaposi’s sarcoma Primary Effusion Lymphoma (classic and solid variants) Plasmablastic lymphomas |
Extracavitary KSHV positive solid lymphoma Early PEL Germinotrophic lymphoproliferation |
HPV-16 | Cancers of the cervix, vulva, vagina, penis, anus, oral cavity, oropharynx, and tonsil | Cancer of the larynx |
HPV-18, 31, 33,35, 39, 45, 51, 52, 56, 58, and 59 | Cervical cancer |